Tianrong Pan

7PUBLICATIONS
15CO-AUTHORS
PainCancer therapy (excl. chemotherapy and radiation therapy)Development cooperationImmunogenetics (incl. genetic immunology)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 23, 2026
Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial.

Xiaohui Guo, Kailiang Wang, Tingting Zhang

|Jan 07, 2026
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial.

Dalong Zhu, Weimin Wang, Guoyu Tong

|Dec 08, 2025
Remnant Cholesterol Inflammatory Index and New-Onset Diabetes in Middle-Aged and Older Adults: Evidence From Prospective Surveys of Chinese and UK Populations.

Nan Chen, Ajuan Gong, Xiaomin Huang

|Aug 05, 2025
Iodine uptake variability as a predictive biomarker for radioiodine therapy outcomes in Graves Disease: Validation through multi-time-point RAIU assessment in a 1249-patient cohort.

Yifan Li, Meiwen He, Zilong Hu

|Nov 03, 2024
Increased FT3/FT4 ratio in a certain range is associated with decreased glycemic variability in patients with type 2 diabetes.

Ying Li, Tianrong Pan, Lingyu Wang

|Oct 22, 2024
Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trial.

Leili Gao, Fang Bian, Tianrong Pan

Pageof 2

Frequent Collaborators

2 joint publications

Jia Sun

1 joint publications

Meiwen He

1 joint publications

Leili Gao

1 joint publications

Linong Ji